Zurueck zur Suche

Reporte zur Charge U019139

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
0Hospitalisiert
1Lebensbedrohlich
1Bleibende Schaeden
IA 1 IL 1 WI 1 FL 1 NY 1 MI 1 CO 1 OH 1

VAERS 2585575

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U019139

schwer
Staat
IA
Alter
52,0
Geschlecht
M
Eingang
22.02.2023
Impfdatum
11.10.2022
Beginn
14.10.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Antinuclear antibody negative Blood glucose normal Demyelination Electromyogram abnormal Guillain-Barre syndrome Hypoaesthesia Injection site pain Myopathy Nerve conduction studies abnormal Neuropathy peripheral Pain in extremity Paraesthesia Pruritus Sensorimotor disorder Thyroid function test normal Vitamin B12 normal

Symptomtext

I have been having some issues since you gave me my HEP B vaccine. It started Friday morning and has been getting worse ever since. Started with the tips of my fingers and toes on my right side going numb. As they day went on the numbness spread. As the weekend progress that spread to both hands and feet and up to my knees and elbows and had that itchy numbness in my feet. After that, my right arm and shoulder have been in extreme pain. I have pins and needles in both feet and hands 24/7. Have you ever had anyone experience this? And if so, how did they make it stop? I am at the point where I just want to cut my arm off to make the pain stop.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
-
Labordaten
10/19/22- Non fasting glucose was 140 B12 normal Thyroid normal Anti-nuclear negative 10/28/22 Nerve Conduction Study Impression: This is an abnormal EMG/NCS Taken as a whole, these findings are suggestive of a generalized sensorimotor neuropathic disorder with distal demyelinating features. With the apparent subacute onset of symptoms, acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barre) should be considered. However, additional considerations include focal serve bilateral median sensorimotor mononeuropathies consistent carpal tunnel syndrome and mild bilateral ulnar neuropathies at the elbow, each due to mechanical compression, although these more focal processes would not explain the very subtle findings noted in the lower extremities with nerve conduction studies. There is no convincing evidence of a structurally mediated radiculopathy affecting the bilateral upper or lower extremities. There is also no evidence of a generalized myopathic disorder.
Aktuelle Erkrankungen
None
Vorgeschichte
Intermittent Premature Atrial Contractions
Andere Medikamente
none
Allergien
Oxycodone
Vorherige Impfungen
-

VAERS 2676131

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U019139

gering
Staat
IL
Alter
42,0
Geschlecht
F
Eingang
24.08.2023
Impfdatum
01.08.2023
Beginn
01.08.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient has not had any symptoms/ No additional AE/no PQC; a patient received an expired dose of RECOMBIVAX HB; This spontaneous report was received from a medical assistant referring to a 42 years old female patient. The patient's pertinent medical history, drug reactions/allergies, concurrent condition and concomitant medication were not provided. On an unknown date, the patient was vaccinated with the first dose of hepatitis B vaccine (recombinant) (RECOMBIVAX HB) 0.5 ml for prophylaxis (strength, route of administration, lot number and expiration date were not reported). On 01-AUG-2023, the patient was vaccinated with the second dose of hepatitis B vaccine (recombinant) (RECOMBIVAX HB) (lot# U019139, expiration date reported as 30-JUN-2023, but upon internal validation established as 11-JUN-2023; strength, dose and route of administration were not reported) in left deltoid (LD) at private doctor's office/hospital (expired product administered). The patient had no side effects at the reporting time, and she was feeling okay.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2655912

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U019139

gering
Staat
WI
Alter
18,0
Geschlecht
F
Eingang
13.07.2023
Impfdatum
06.06.2023
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Recumbivax-Adult was administered. At time of next dose, noted that this client was 18 y/o not the required 20y/o

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2652115

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U019139

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
03.07.2023
Impfdatum
12.06.2023
Beginn
12.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE; Nurse calling to report an AAE regarding the RECOMBIVAX HB vaccine. Nurse reported that a patient was administered an expired dose of the vaccine. Permission to contact HCP was provided. No additional AE/PQC reported.; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported. On 12-JUN-2023, the patient was vaccinated with an expired dose of hepatitis b vaccine (recombinant)(RECOMBIVAX HB) lot # U019139, expiration date: 11-JUN-2023 (strength, route of administration, anatomical location not provided) as prophylaxis. No additional adverse event was reported. .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2637425

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U019139

gering
Staat
NY
Alter
0,1
Geschlecht
F
Eingang
26.05.2023
Impfdatum
26.05.2023
Beginn
26.05.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered No adverse event Product administered to patient of inappropriate age

Symptomtext

Infant was given Hep B vaccination today. Was inadvertently administered adult formulation of vaccine at 10mcg (1cc) versus pediatric 5mcg (0.5cc), no adverse reactions occurred at time of administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2621857

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U019139

gering
Staat
MI
Alter
-
Geschlecht
U
Eingang
27.04.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Product use issue

Symptomtext

a 18 years old patient received an adult dose of RECOMBIVAX; This spontaneous report was received from another health professional and referred to an 18-year-old. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with a dose of hepatitis B vaccine (recombinant) (RECOMBIVAX HB) intramuscular injection, 1 ml, with a reported and validated: lot #U019139, and expiration date of 11-JUN-2023, administered for prophylaxis (strength, and route of administration were not provided). However, the 18 years old patient received an adult dose of hepatitis B vaccine (recombinant) (RECOMBIVAX HB) (Drug use in unapproved age group).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2610068

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U019139

gering
Staat
CO
Alter
46,0
Geschlecht
F
Eingang
05.04.2023
Impfdatum
05.04.2023
Beginn
01.04.2023
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration

Symptomtext

Vaccine was administered as an intramuscular instead of subcutaneous.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2566802

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U019139

gering
Staat
OH
Alter
18,0
Geschlecht
F
Eingang
24.01.2023
Impfdatum
29.12.2022
Beginn
24.01.2023
Tage bis Beginn
26,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered Incorrect dose administered

Symptomtext

Patient inadvertently given 1.0mL dose of "adult" hepatitis B vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
Is 4th dose of hepatitis B vaccine as pt verbally reported negative titer for hepatitis B.
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
gluten
Vorherige Impfungen
-

VAERS 2526717

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U019139

gering
Staat
-
Alter
7,0
Geschlecht
F
Eingang
08.12.2022
Impfdatum
21.11.2022
Beginn
21.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Patient was given an adult Hep B vaccine instead of a pediatric dose. Patient was given a DTaP instead of a TDaP vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-